Zota Health Care LImited — Investor Meet, 10-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Zota Healthcare reported Q3FY26 consolidated revenue of INR 142.95 Cr, up 98.2% YoY, with Gross Profit up 113.9% to INR 86.18 Cr. Consolidated EBITDA stood at INR 1.28 Cr, impacted by aggressive store expansion costs, which are expected to normalize.

The Davaindia network grew to 2,331 stores, adding 276 in Q3. A INR 350 Cr Qualified Institutional Placement was completed to fund COCO store rollout and working capital. The company acquired Curexis (SKIA brand) to expand its retail pharmacy footprint, targeting 5,000 Davaindia stores by March 2029. Management maintains a confident outlook on future profitability as new stores mature.